Document is current

Any future updates will be listed below

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Crossref DOI link: https://doi.org/10.1007/s10549-017-4537-5

Published Online: 2017-10-23

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark